MicroRNA Therapeutics: the Next Magic Bullet?

Author(s): Bridget Simonson, Saumya Das

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 15 , Issue 6 , 2015

Become EABM
Become Reviewer
Call for Editor


MicroRNAs are short noncoding 18-25 nucleotide long RNA which bind and inhibit mRNA. Currently, there are over 1000 known human microRNAs, and microRNAs control over 50% of mammalian protein coding genes. MicroRNAs can be overexpressed or repressed in different diseases and inhibition or replacement of microRNAs is a promising area of study for therapeutics. Here we review the current knowledge of microRNA therapy, and discuss ways in which they can be utilized. We also discuss different methods of delivery of miRNA, and current clinical trials of microRNA-based therapies for disease. Finally we discuss the current limitations in the field, and how these limitations are being overcome.

Keywords: Antagomir, clinical trial, delivery, microRNA, microRNA mimic, therapeutic.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 21 April, 2015
Page: [467 - 474]
Pages: 8
DOI: 10.2174/1389557515666150324123208
Price: $65

Article Metrics

PDF: 69